Biofrontera Inc. Q2 Loss Declines; Maintains FY22 Outlook - Update

(Adds outlook)

Biofrontera Inc. (BFRI) announced Loss for second quarter that decreased from last year

The company's earnings came in at -$0.85 million, or -$0.05 per share. This compares with -$3.66 million, or -$0.46 per share, in last year's second quarter.

The company's revenue for the quarter fell 23.9% to $4.45 million from $5.85 million last year.


Moving forward, for the fiscal 2022, the company still expects a rise in total revenues by at least 30 percent, compared with the previous fiscal. For the fiscal 2021, the drug maker had registered total sales of $24.1 million.

Biofrontera Inc. earnings at a glance (GAAP) :

-Earnings (Q2): -$0.85 Mln. vs. -$3.66 Mln. last year.
-EPS (Q2): -$0.05 vs. -$0.46 last year.
-Revenue (Q2): $4.45 Mln vs. $5.85 Mln last year.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT